Business Wire

EGYPTIAN-TOURISM

16.3.2023 14:11:45 CET | Business Wire | Press release

Share
Egypt Beats Classic UK Holiday Destinations in Both Attractiveness and Price

The most popular foreign destinations for British holidaymakers are Italy and Spain. However, what many travellers do not know: For the price they spend on a holiday in these countries, they could experience more luxury and adventure in Egypt.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230216005515/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Winter in Egypt (Photo: Business Wire)

What Brits pay for their holidays abroad

Brits love to travel, but how much do they actually spend on their holidays? According to National Institute of statistics (Ine), the British invested an average of £1,0001 per person on a trip in 2021. However, a one-week stay including meals in a three-star hotel in Italy, for example, can cost up to £1,300 even in the low season. And that doesn't even include sightseeing, theatre tickets or museum visits.

In Egypt, two people can spend seven nights in a five-star hotel for less than the average price of a holiday in an Italian coastal region - all-inclusive, of course. The return flight from a major UK city is also included here. This leaves a lot of the budget for excursions and activities.

From paradisiacal beaches to the impressive expanse of the desert

Egypt has a lot to offer for all travelers - whether they are sun worshippers looking to relax on the beautiful coasts or culture vultures in search of ancient sites steeped in history. "Over the past two years, when we had restrictions on travel due to the pandemic, Egypt has been improving its travel infrastructure and working to expand what it has to offer visitors," says Amr El-Kady, managing director of the Egyptian Tourism Authority. "Even tourists who have visited Egypt before will now be able to discover many new options for things to do and interesting things to see. There are numerous, fantastic new accommodations available as domiciles."

For beach and sea lovers, the entire Egyptian coast is an ideal destination. You'll find plenty of white sandy beaches and warm, crystal-clear waters on both the Mediterranean and the Red Sea. From the beach resorts in Sharm El Sheikh on the Sinai Peninsula and Hurghada on Egypt's east coast, you can enjoy breathtaking views over the Red Sea. From here, you can also explore the mystical mountain regions inland. The Red Sea is also home to some of the most beautiful coral reefs in the world and can be explored by both amateur and professional divers. The Mediterranean coast from Alexandria to Marsa Matruh also beckons with turquoise waters and seemingly endless sandy beaches that invite you to swim, dive and sunbathe.

Those who prefer to discover and enjoy the incomparable beauty of the desert will not be disappointed either and can expect an experience like from 1001 Nights. In the Sinai desert, hiking and camel safaris offer an unforgettable experience for outdoor enthusiasts.

Tradition and history in the cities of the pharaohs

Among the most impressive historical sites is the magnificent city of Luxor with its spectacular sights such as the Valley of the Kings, the Temple of Karnak, and the legendary Luxor Temple. For a special experience, take a hot air balloon ride for a majestic view of the city on the Nile from above.

Fans of city trips should have Cairo on their agenda: In the Egyptian capital, millennia-old relics of antiquity meet the modern culture of the Middle East. The Great Sphinx and the Pyramids of Giza - the only remaining wonder of the ancient world - are unique buildings and an impressive testimony to ancient architecture. The history of the country is also presented in detail in the Egyptian Museum: It houses over 120,000 artefacts, including the treasures from Tutankhamun's tomb.

The Khan El Khalili bazaar is one of the oldest and most famous markets in the Middle East: here, holidaymakers can not only find authentic souvenirs but also enjoy the specialties of the local cuisine and get to know contemporary Egyptian culture.

Anyone looking for a multifaceted, historical and affordable travel destination should try Egypt to see for themselves the rich variety of this country with their own eyes and senses.

1 Ine (2022) Gasto de los turistas internacionales segun pais de residencia. Taken from: https://www.ine.es/jaxiT3/Datos.htm?t=10838#!tabs-tabla

– ENDE –

For further information:
https://www.experienceegypt.eg/

About the Egyptian Tourism Board

The Egyptian Tourism Board, established in 1981, is a regulatory body affiliated with the Ministry of Tourism. Its mission is to stimulate international tourism by promoting Egypt's rich history and civilization and highlighting the country's many tourist attractions. It also aims to promote domestic tourism, raise awareness of tourism throughout the country and strengthen the link between Egyptians and their heritage.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230216005515/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release

Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely

MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release

The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav

New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 10:00:00 CEST | Press release

Analyses from the multinational MILOS study show that LDL-C reductions achieved with up to one year of treatment with bempedoic acid-containing therapies translate to a 17.1% relative reduction and a 4.8% absolute reduction in predicted 10-year cardiovascular risk.1 Real-world data demonstrated clinically relevant mean LDL-C reductions of at least 24.9%, regardless of patient gender or glycaemic status, after one year of follow-up.2,3 Findings presented at ESC Congress 2026 reinforce the clinical value of bempedoic acid in routine clinical practice, and demonstrate the continued investment of Daiichi Sankyo in addressing outstanding unmet needs in cardiovascular disease (CVD). Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich,

TVS Motor Company Appoints Peyman Kargar as Director and Chief Executive Officer28.8.2026 09:31:00 CEST | Press release

Peyman Kargar appointed Director and Chief Executive Officer of TVS Motor Company, effective January 27, 2027 K. N. Radhakrishnan to continue as Director and Chief Executive Officer until then and subsequently will serve as Non-Executive Director up to the date of the ensuing AGM scheduled in July 2027 Appointment supports TVS Motor Company's next phase of growth and innovation TVS Motor Company, part of TVS VENU and a leading global manufacturer of two and three-wheelers, today announced the appointment of Peyman Kargar as Director and Chief Executive Officer, effective January 27, 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260827012301/en/ Peyman Kargar Peyman will succeed K. N. Radhakrishnan, who will continue in his role until then to ensure a seamless transition. Following the transition, Radhakrishnan will serve as Non-Executive Director up to the date of the ensuing AGM scheduled in July 2027. He has been a

Philips and Imricor Launch Cardiac Interventional MR Lab Solution, Expanding Longstanding Collaboration27.8.2026 21:27:00 CEST | Press release

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Imricor Medical Systems (ASX: IMR), a pioneer and world-leading developer of MR-compatible products for interventional MR procedures, today announced a new Interventional MR (iMR) lab solution for Philips 1.5T MR. The first commercially available configuration* combines Philips’ 1.5T MRI platform and Imricor's portfolio of iMR systems and consumables, enabling an MR-guided workflow for cardiac intervention, without compromising on MR field strength. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260827693715/en/ Meeting the need for greater tissue insight during cardiac intervention Cardiac arrhythmias affect millions of people worldwide, and catheter ablation is an established and increasingly utilized treatment for many complex cardiac arrhythmias. Yet today, these procedures continue to rely primarily on X-ray fluoroscopy, which provides only

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye